Data PROpel Lynparza To Potential Prostate Cancer Megablockbuster

Combo Of PARP Inhibitor And J&J's Zytiga Delays Progression In All-Comers

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.